Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT. J of Skin 2020, 4 (6), s85. https://doi.org/10.25251/skin.4.supp.85.